1. Home
  2. LUNG vs ACR Comparison

LUNG vs ACR Comparison

Compare LUNG & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • ACR
  • Stock Information
  • Founded
  • LUNG 1995
  • ACR 2005
  • Country
  • LUNG United States
  • ACR United States
  • Employees
  • LUNG N/A
  • ACR N/A
  • Industry
  • LUNG Industrial Specialties
  • ACR Real Estate Investment Trusts
  • Sector
  • LUNG Health Care
  • ACR Real Estate
  • Exchange
  • LUNG Nasdaq
  • ACR Nasdaq
  • Market Cap
  • LUNG 124.0M
  • ACR 139.0M
  • IPO Year
  • LUNG 2020
  • ACR N/A
  • Fundamental
  • Price
  • LUNG $2.78
  • ACR $18.19
  • Analyst Decision
  • LUNG Buy
  • ACR Buy
  • Analyst Count
  • LUNG 6
  • ACR 2
  • Target Price
  • LUNG $11.53
  • ACR $17.50
  • AVG Volume (30 Days)
  • LUNG 311.3K
  • ACR 79.8K
  • Earning Date
  • LUNG 07-30-2025
  • ACR 07-30-2025
  • Dividend Yield
  • LUNG N/A
  • ACR N/A
  • EPS Growth
  • LUNG N/A
  • ACR N/A
  • EPS
  • LUNG N/A
  • ACR 0.34
  • Revenue
  • LUNG $87,473,000.00
  • ACR $83,545,000.00
  • Revenue This Year
  • LUNG $18.02
  • ACR $3.57
  • Revenue Next Year
  • LUNG $18.17
  • ACR N/A
  • P/E Ratio
  • LUNG N/A
  • ACR $53.02
  • Revenue Growth
  • LUNG 19.84
  • ACR 6.92
  • 52 Week Low
  • LUNG $2.50
  • ACR $13.07
  • 52 Week High
  • LUNG $9.37
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.83
  • ACR 53.13
  • Support Level
  • LUNG $2.52
  • ACR $17.80
  • Resistance Level
  • LUNG $2.84
  • ACR $18.45
  • Average True Range (ATR)
  • LUNG 0.16
  • ACR 0.51
  • MACD
  • LUNG 0.04
  • ACR 0.08
  • Stochastic Oscillator
  • LUNG 46.36
  • ACR 81.29

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: